CVE-2002-1636
Cross-site scripting (XSS) vulnerability in the htp PL/SQL package for Oracle 9i Application...
Cross-site scripting (XSS) vulnerability in the htp PL/SQL package for Oracle 9i Application Server (9iAS) allows remote attackers to inject arbitrary web script or HTML via the cbuf parameter to htp.print.
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting (XSS) vulnerability in the htp PL/SQL package for Oracle 9i Application Server (9iAS) allows remote attackers to inject arbitrary web script or HTML via the cbuf parameter to htp.print.
- Record
CVE-2002-1636- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in the htp PL/SQL package for Oracle 9i Application Server (9iAS) allows remote attackers to inject arbitrary web script or HTML via the cbuf parameter to htp.print.
- Record
CVE-2002-1636- Updated
- 2026-11-02
EUVDEUVD-2002-1617 No score
Cross-site scripting (XSS) vulnerability in the htp PL/SQL package for Oracle 9i Application Server (9iAS) allows remote attackers to inject arbitrary web script or HTML via the cbuf parameter to htp.print.
- Record
EUVD-2002-1617- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-6jvf-9896-2hgg No score
Cross-site scripting (XSS) vulnerability in the htp PL/SQL package for Oracle 9i Application...
Cross-site scripting (XSS) vulnerability in the htp PL/SQL package for Oracle 9i Application Server (9iAS) allows remote attackers to inject arbitrary web script or HTML via the cbuf parameter to htp.print.
- Record
GHSA-6jvf-9896-2hgg- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2002-1636 is a medium vulnerability (CVSS 4.3) in Oracle Application Server, published December 31, 2002. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.55%, the 75th percentile. No source names a fixed version.